Find a Doctor

HU
Areas of Expertise

Hideki Ueno

National Defense Medical College
Male

Bio

Hideki Ueno is in Tokyo, Japan. They have been an author on 412 peer reviewed articles in the past 15 years.

Areas of Expertise

Contact

Tokyo, JP

Latest Research

Latest Advance
Study
  • Condition: Resected Pancreatic Cancer
  • Journal: Pancreas
  • Treatment Used: Nab-Paclitaxel Plus Gemcitabine
  • Number of Patients: 41
  • Published —
The study researched the outcomes of nab-paclitaxel plus gemcitabine for treating resected pancreatic cancer.
Latest Advance
Study
  • Condition: Esophageal Cancer
  • Journal: In vivo (Athens, Greece)
  • Treatment Used: Antiplatelet and Anticoagulant Therapies
  • Number of Patients: 176
  • Published —
This study investigated the relationship between platelet-related prognostic markers and anti-platelet or anti-coagulant therapies for survival outcomes in patients with esophageal squamous cell carcinoma.
Latest Advance
Study
  • Condition: Amebic Liver Abscess Refractory to Metronidazole (MNZ) and Percutaneous Drainage
  • Journal: BMC surgery
  • Treatment Used: Surgical Drainage with Intraoperative Ultrasonography
  • Number of Patients: 1
  • Published —
This case report discusses a 53-year-old man with amebic liver abscess refractory to metronidazole (MNZ) treated with preoperative computed tomography (CT) and percutaneous and surgical drainage with intraoperative ultrasonography (IOUS).
Latest Advance
Study
  • Condition: Microsatellite-stable stage III colorectal cancer
  • Journal: Diseases of the colon and rectum
  • Treatment Used: microsatellite-stable stage III colorectal cancer with curatively intended surgery (R0)
  • Number of Patients: 549
  • Published —
This study evaluated the clinical benefits of including fluorouracil-based adjuvant chemotherapy in patients with microsatellite-stable stage III colorectal cancer with curatively intended surgery (R0). Researchers compared two groups with the same cancer diagnosis either receiving the adjuvant therapy or not.
Latest Advance
Study
  • Condition: Locally Advanced Pancreatic Cancer
  • Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
  • Treatment Used: FOLFIRINOX
  • Number of Patients: 66
  • Published —
This study tested the safety and efficacy of using FOLFIRINOX to treat patients with locally advanced pancreatic cancer.
Latest Advance
Study
  • Condition: Gemcitabine-Refractory Advanced Pancreatic Cancer
  • Journal: European journal of cancer (Oxford, England : 1990)
  • Treatment Used: S-1 (Oteracil) plus Leucovorin versus S-1 (Oteracil)
  • Number of Patients: 603
  • Published —
The purpose of the study was to evaluate the effectiveness of S-1 plus leucovorin versus S-1 in overall survival in patients with gemcitabine-refractory advanced pancreatic cancer.
Latest Advance
Study
  • Condition: Advanced solid tumors
  • Journal: Investigational new drugs
  • Treatment Used: Taladegib
  • Number of Patients: 19
  • Published —
This study evaluated the safety and tolerability of taladegib in patients with advanced solid tumors.

Clinical Trials

This doctor has not participated in any recent clinical trials.

All Publications
View All

Publication
Study
  • Journal: Pancreas
  • Published —
Tolerability of Nab-Paclitaxel Plus Gemcitabine as Adjuvant Setting in Japanese Patients With Resected Pancreatic Cancer: Phase I Study.
Publication
Study
  • Journal: Acta medica Okayama
  • Published —
Bilateral Approach for Thoracoscopic Esophagectomy in a Patient with Esophageal Cancer and Solitary Posterior Thoracic Para-aortic Lymph Node Metastasis.

Contact

Tokyo, JP

Insurance

Contact them to find out if they accept your insurance plan.